Published • loading... • Updated
Hanmi Pharmaceutical’s Obesity Drug ‘Effe’ Production Base Receives Highest Safety Rating
Summary by 조선일보
1 Articles
1 Articles
Hanmi Pharmaceutical announced on the 31st that its Pyeongtaek Manufacturing Center, a global biopharmaceutical production base, has received the highest rating, ‘Grade P,’ in the Ministry of Employment and Labor’s Process Safety Management (PSM) evaluation for the second consecutive time. As Hanmi Group’s global biopharmaceutical production base, the Pyeongtaek Manufacturing Center is a key production hub responsible for the domestic and intern…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right1Center0Last UpdatedBias Distribution100% Right
Bias Distribution
- 100% of the sources lean Right
100% Right
R 100%
Factuality
To view factuality data please Upgrade to Premium
